中文 | English
Return
Total: 158 , 1/16
Show Home Prev Next End page: GO
MeSH:(Schistosomiasis*)

1.Distribution characteristics of emerging and reemerging Oncomelania hupensis in China from 2015 to 2021.

F YANG ; T FENG ; J HE ; L ZHANG ; J XU ; C CAO ; S LI

Chinese Journal of Schistosomiasis Control 2023;35(5):437-443

2.Spatial distribution characteristics of the prevalence of advanced schistosomiasis and seroprevalence of anti-Schistosoma antibody in Hunan Province in 2020.

Y ZHOU ; L TANG ; Y TONG ; J HUANG ; J WANG ; Y ZHANG ; H JIANG ; N XU ; Y GONG ; J YIN ; Q JIANG ; J ZHOU ; Y ZHOU

Chinese Journal of Schistosomiasis Control 2023;35(5):444-450

3.Construction of a surveillance and early warning index system for schistosomiasis transmission risk along the middle and lower reaches of the Yangtze River basin.

S JIANG ; L WANG ; L SUN ; T LIU ; Y LIU ; X LIU

Chinese Journal of Schistosomiasis Control 2023;35(5):486-491

4.Schistosomiasis and soil-transmitted helminthiasis morbidity control in selected communities in Eastern Visayas, Philippines: Post-Haiyan

Mary Ann J. Ladia, PhD ; Vicente Y. Belizario, Jr., MD, MTMH ; Jana M. Lacuna, RMT ; Lourivy P. Durano, RMT, MSPH ; Allen I. Alonte, RMT

Acta Medica Philippina 2023;57(7):24-30

5.Prevalence of comorbid depression and anxiety and effect of psychological interventions among schistosomiasis patients in China: a meta-analysis.

M WANG ; G JIN ; Y CHENG ; J ZHENG ; L TIAN ; S ZHANG ; W HONG

Chinese Journal of Schistosomiasis Control 2023;35(4):340-348

6.Spatial distribution of Oncomelania hupensis spread in Hubei Province from 2020 to 2022.

Y CHEN ; Y XIAO ; F WEI ; J YANG ; L DAI ; C ZHONG ; J LIU

Chinese Journal of Schistosomiasis Control 2023;35(4):349-357

7.Construction of a schistosomiasis transmission risk assessment system in Wuhan City based on analytic hierarchy process.

Y ZUO ; M XU ; Y LI ; S WANG ; S ZHOU ; H LUO

Chinese Journal of Schistosomiasis Control 2023;35(4):374-378

8.Exploring the effects of artesunate and fuzheng huayu decoction on mitochondria in the treatment of schistosomiasis liver fibrosis.

Jun Tao LUO ; Sheng Nan QIAN ; Kai Yue WU ; Si Cheng ZHU ; Yi Lei HUANG ; Jian Ping YE ; Shuang SHEN

Chinese Journal of Hepatology 2022;30(1):45-51

9.Analysis of the new WHO guideline to accelerate the progress towards elimination of schistosomiasis in China.

Zhao Yu GUO ; Jia Xin FENG ; Li Juan ZHANG ; Yi Biao ZHOU ; Jie ZHOU ; Kun YANG ; Yang LIU ; Dan Dan LIN ; Jian Bing LIU ; Yi DONG ; Tian Ping WANG ; Li Yong WEN ; Min Jun JI ; Zhong Dao WU ; Qing Wu JIANG ; Song LIANG ; Jia Gang GUO ; Chun Li CAO ; Jing XU ; Shan LÜ ; Shi Zhu LI ; Xiao Nong ZHOU

Chinese Journal of Schistosomiasis Control 2022;34(3):217-222

10.Decoding the evolution of preventive chemotherapy schemes for schistosomiasis in China to improve the precise implementation of the WHO guideline on control and elimination of human schistosomiasis.

Jing XU ; Yi Feng LI ; Yi DONG ; Zheng Yuan ZHAO ; Li Yong WEN ; Shi Qing ZHANG ; Dan Dan LIN ; Jie ZHOU ; Song LIANG ; Jia Gang GUO ; Shi Zhu LI ; Xiao Nong ZHOU

Chinese Journal of Schistosomiasis Control 2022;34(3):223-229

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 158 , 1/16 Show Home Prev Next End page: GO